Twin Focus Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,122
| Closed | -$354K | – | 238 |
|
|
2023
Q1 | $354K | Hold |
1,122
| – | – | 0.07% | 142 |
|
|
2022
Q4 | $324K | Hold |
1,122
| – | – | 0.07% | 147 |
|
|
2022
Q3 | $325K | Sell |
1,122
-20
| -2% | -$5.79K | 0.08% | 136 |
|
|
2022
Q2 | $322K | Sell |
1,142
-22
| -2% | -$6.2K | 0.07% | 142 |
|
|
2022
Q1 | $304K | Sell |
1,164
-34
| -3% | -$8.88K | 0.06% | 160 |
|
|
2021
Q4 | $263K | Buy |
1,198
+93
| +8% | +$20.4K | 0.05% | 184 |
|
|
2021
Q3 | $200K | Buy |
1,105
+7
| +0.6% | +$1.27K | 0.05% | 182 |
|
|
2021
Q2 | $221K | Buy |
1,098
+26
| +2% | +$5.23K | 0.05% | 175 |
|
|
2021
Q1 | $230K | Buy |
1,072
+52
| +5% | +$11.2K | 0.07% | 135 |
|
|
2020
Q4 | $241K | Buy |
1,020
+40
| +4% | +$9.45K | 0.07% | 135 |
|
|
2020
Q3 | $267K | Buy |
980
+27
| +3% | +$7.36K | 0.1% | 111 |
|
|
2020
Q2 | $277K | Sell |
953
-1
| -0.1% | -$291 | 0.11% | 109 |
|
|
2020
Q1 | $227K | Buy |
954
+18
| +2% | +$4.28K | 0.1% | 125 |
|
|
2019
Q4 | $205K | Buy |
+936
| New | +$205K | 0.07% | 186 |
|